An Old AML Drug Revisited  

Oleh:

Dombret, Herve ; Gardin, Claude

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 361 no. 13 (Sep. 2009), page 1301-1303.
Topik: AML

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2009.05 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Acute myeloid leukemia (AML) is a heterogeneous hematologic cancer whose wide range of outcomes probably reflects the accumulation of various acquired mutations that block the differentiation of blood-cell progenitors or confer a proliferative advantage to the malignant clone. Current therapies can cure approximately 40% of young patients, but outcomes are much worse in patients over the age of 60 years, who constitute the majority of cases of AML.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali